back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-08-03 18:41 Tx date 2023-08-01 |
$REUN
Reunion Neuroscience Inc. (formerly Field Trip Health Ltd.) |
Bryson, Nathan John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-82,000 vol |
0 | |
| Filed 2023-08-03 18:40 Tx date 2023-08-01 |
$REUN
Reunion Neuroscience Inc. (formerly Field Trip Health Ltd.) |
Bryson, Nathan John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-1,166 vol |
0 | |
| Filed 2022-08-17 17:11 Tx date 2022-08-11 |
$REUN
Reunion Neuroscience Inc. (formerly Field Trip Health Ltd.) |
Bryson, Nathan John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-328,000 vol |
82,000 | |
| Filed 2022-08-17 17:10 Tx date 2022-08-11 |
$REUN
Reunion Neuroscience Inc. (formerly Field Trip Health Ltd.) |
Bryson, Nathan John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-4,665 vol |
1,166 | |
| Filed 2022-06-01 21:47 Tx date 2022-05-31 |
$FTRP
Field Trip Health Ltd. |
Bryson, Nathan John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
410,000 | |
| Filed 2021-06-22 08:19 Tx date 2021-05-31 |
$FTRP
Field Trip Health Ltd. |
Bryson, Nathan John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+60,000 vol |
360,000 | |
| Filed 2021-03-24 19:47 Tx date 2020-10-01 |
$FTRP
Field Trip Health Ltd. (formerly Newton Energy Corporation) |
Bryson, Nathan John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-03-17 15:23 Tx date 2020-10-01 |
$FTRP
Field Trip Health Ltd. (formerly Newton Energy Corporation) |
Bryson, Nathan John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-03-17 15:24 Tx date 2021-03-17 |
$FTRP
Field Trip Health Ltd. (formerly Newton Energy Corporation) |
Bryson, Nathan John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$37,901
+5,831 vol $6.50 each |
11,662 | |
| Filed 2021-03-17 15:23 Tx date 2020-10-01 |
$FTRP
Field Trip Health Ltd. (formerly Newton Energy Corporation) |
Bryson, Nathan John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
5,831 | ||
| Filed 2020-10-09 15:10 Tx date 2020-10-01 |
$FTRP
Field Trip Health Ltd. (formerly Newton Energy Corporation) |
Bryson, Nathan John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
300,000 | ||
| Filed 2018-03-26 Tx date 2018-03-23 |
$ASP
Acerus Pharmaceuticals Corporation |
Bryson, Nathan John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+316,598 vol |
2,701,598 | |
| Filed 2017-11-13 Tx date 2017-11-09 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Bryson, Nathan John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$60,000
+500,000 vol $0.12 each |
2,385,000 | |
| Filed 2017-06-02 Tx date 2017-06-02 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Bryson, Nathan John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,680
+39,000 vol $0.12 each |
424,500 | |
| Filed 2017-03-13 Tx date 2017-03-10 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Bryson, Nathan John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+600,000 vol |
1,885,000 | |
| Filed 2017-03-13 Tx date 2017-03-10 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Bryson, Nathan John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,000
+100,000 vol $0.11 each |
385,500 | |
| Filed 2016-11-23 Tx date 2016-11-23 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Bryson, Nathan John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,729
+100,000 vol $0.1473 each |
285,500 | |
| Filed 2016-08-23 Tx date 2016-08-23 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Bryson, Nathan John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,600
+60,000 vol $0.16 each |
185,500 | |
| Filed 2016-06-22 Tx date 2016-06-21 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Bryson, Nathan John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,800
+60,000 vol $0.13 each |
125,500 | |
| Filed 2016-03-30 Tx date 2016-03-24 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Bryson, Nathan John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,500
+45,000 vol $0.10 each |
65,500 | |
| Filed 2016-03-08 Tx date 2016-03-04 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Bryson, Nathan John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+950,000 vol |
1,285,000 | |
| Filed 2015-12-23 Tx date 2015-12-23 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Bryson, Nathan John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,575
+9,000 vol $0.175 each |
20,500 | |
| Filed 2015-12-23 Tx date 2015-12-23 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Bryson, Nathan John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,190
+7,000 vol $0.17 each |
11,500 | |
| Filed 2015-08-13 Tx date 2015-08-13 |
$TRL
Trimel Pharmaceuticals Corporation (formerly J5 Acquisition Corp.) |
Bryson, Nathan John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,800
+4,500 vol $0.40 each |
4,500 | |
| Filed 2015-08-13 Tx date 2014-02-17 |
$TRL
Trimel Pharmaceuticals Corporation (formerly J5 Acquisition Corp.) |
Bryson, Nathan John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|